The Chemours Company
CC
$20.22
-$0.64-3.07%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.38B | 1.33B | 1.50B | 1.62B | 1.37B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.38B | 1.33B | 1.50B | 1.62B | 1.37B |
| Cost of Revenue | 1.17B | 1.17B | 1.26B | 1.34B | 1.13B |
| Gross Profit | 212.00M | 159.00M | 235.00M | 278.00M | 236.00M |
| SG&A Expenses | 145.00M | 105.00M | 105.00M | 178.00M | 121.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.34B | 1.30B | 1.39B | 1.54B | 1.28B |
| Operating Income | 41.00M | 27.00M | 104.00M | 72.00M | 88.00M |
| Income Before Tax | -22.00M | -67.00M | 51.00M | -261.00M | 0.00 |
| Income Tax Expenses | 7.00M | -5.00M | -9.00M | 119.00M | 5.00M |
| Earnings from Continuing Operations | -29.00M | -62.00M | 60.00M | -380.00M | -5.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 1.00M | -- | -1.00M | -- |
| Net Income | -29.00M | -61.00M | 60.00M | -381.00M | -5.00M |
| EBIT | 41.00M | 27.00M | 104.00M | 72.00M | 88.00M |
| EBITDA | 120.00M | 131.00M | 183.00M | 152.00M | 176.00M |
| EPS Basic | -0.19 | -0.41 | 0.40 | -2.54 | -0.03 |
| Normalized Basic EPS | 0.00 | -0.13 | 0.21 | 0.05 | 0.12 |
| EPS Diluted | -0.19 | -0.41 | 0.40 | -2.54 | -0.03 |
| Normalized Diluted EPS | 0.00 | -0.13 | 0.21 | 0.05 | 0.12 |
| Average Basic Shares Outstanding | 152.63M | 150.47M | 150.32M | 150.24M | 166.67M |
| Average Diluted Shares Outstanding | 152.63M | 150.47M | 150.78M | 150.24M | 166.67M |
| Dividend Per Share | -- | 0.09 | 0.09 | 0.09 | 0.25 |
| Payout Ratio | -44.83% | -24.59% | 21.67% | -3.41% | -740.00% |